Recent advances in inhibitors of matrix metalloproteinases for cancer therapy
Related Experiment Video
Updated: Aug 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
1Shionogi Research Laboratories, 5-chome Sagishu, Osaka 553-0002, Japan. kenji.sugita@shionogi.co.jp
Abstract:
Since matrix metalloproteinases (MMPs) have been found to be involved in various diseases, their inhibitors (MMPIs) should be useful as multipotential drugs. Several MMPs are thought to be involved with various diseases in different ways. This review focuses on MMPIs for cancer therapy. MMPIs are expected to be potent antitumor agents with a novel mechanism differing from that of ordinary cytotoxic agents. Numerous studies have been conducted to develop MMPIs for practical use in cancer therapy and some are now in clinical or preclinical stages.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Drugs that Stabilize Microtubules
